Clinical trial
Prospective Evaluation of Infants With Spinal Muscular Atrophy: SPOT SMA
NCT02831296 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Infants With Spinal Muscular Atrophy: SPOT SMA
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 29, 2016
- Completion date
- Not reported
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spinal muscular atrophy